Global Pharmatech, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GBLP research report →
About the company
Global Pharmatech, Inc. engages in the discovery, development, manufacturing, and marketing of proprietary drugs developed based on traditional Chinese medicine. Its operations are based in the People's Republic of China with sales distribution in China, Singapore, Malaysia, Indonesia, and USA.
- CEO
- Mei Sheng Liao
- IPO
- 2002
- Employees
- 217
- HQ
- Hong Kong, MA, HK
Price Chart
- Market Cap
- $33.25M
- P/E
- 800.90
- P/S
- 63.82
- P/B
- -3671.26
- EV/EBITDA
- 702.07
- Div Yield
- 0.00%
- Gross Margin
- 26.84%
- Op Margin
- 6.37%
- Net Margin
- 8.25%
- ROE
- -82.77%
- ROIC
- 40.68%
- Revenue
- $310.89K · 368.39%
- Net Income
- $-67,728 · 51.10%
- EPS
- $-0.00 · 50.00%
- Op Income
- $-67,815
- FCF YoY
- 0.00%
- 52W High
- $0.20
- 52W Low
- $0.05
- 50D MA
- $0.06
- 200D MA
- $0.05
- Beta
- 0.28
- Avg Volume
- 517
Get TickerSpark's AI analysis on GBLP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our GBLP coverage
Recent articles, reports, and earnings notes.
No research on GBLP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GBLP report →Similar companies
Peers in the same neighborhood.